Fig. 1From: Inhibition of discoidin domain receptor (DDR)-1 with nilotinib alters CSF miRNAs and is associated with reduced inflammation and vascular fibrosis in Alzheimer’s diseaseUnbiased next generation whole genome sequencing of CSF miRNA showed expression profiles of a total of 1050 miRNA between baseline and 12 months in the placebo (n = 11) and nilotinib groups (n = 12) (two-way ANOVA)Back to article page